Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Digital Biomarkers is Scopus-indexed (Q1, CiteScore 5.8), DOAJ. Published by S. Karger AG.
Checked against the index lists dated .
ISSN 2504-110XVerify ISSN ↗
Publisher: S. Karger AG
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 101 / 466 | 78th | Q1 |
| Health Informatics | 49 / 168 | 70th | Q2 |
| Computer Science Applications | 316 / 1022 | 69th | Q2 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2017–present, best quartile Q1, CiteScore 5.8.
Digital Biomarkers is Q1 in Medicine (miscellaneous) (rank 101 of 466), Q2 in Health Informatics (rank 49 of 168) and Q2 in Computer Science Applications (rank 316 of 1022), by CiteScore 2025.
Digital Biomarkers is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 5.8, quartile Q1, 78th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.726, quartile Q2, with an H-index of 32.
The publisher lists an article processing charge of about US$990 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Digital Biomarkers is published by S. Karger AG. Its ISSN is 2504-110X.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Digital Biomarkers has an h-index of 39 and a 2-year mean of 3.36 citations per paper (OpenAlex). Its Scopus CiteScore is 5.8, quartile Q1. On 2-year citations it ranks #89 of 451 Scopus journals in Medicine (miscellaneous).
Digital Biomarkers published 20 papers in 2025; its busiest recent year was 2020 with 30. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2021–2026), authors are most often from United States (52.2%), United Kingdom (7.4%) and Germany (6.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.